isoproterenol has been researched along with pyrimidinones in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heber, D; Heers, C; Ravens, U | 1 |
| Johnston, WK; Mahoney, JR; Minnear, FL; Morton, CA; Vincent, PA; Waypa, GB | 1 |
2 other study(ies) available for isoproterenol and pyrimidinones
| Article | Year |
|---|---|
Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Action Potentials; Animals; Cardiotonic Agents; Guinea Pigs; Heart; Humans; In Vitro Techniques; Isoenzymes; Isoproterenol; Male; Milrinone; Myocardial Contraction; Papillary Muscles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridones; Pyrimidinones | 1993 |
Oxidant-increased endothelial permeability: prevention with phosphodiesterase inhibition vs. cAMP production.
Topics: Adrenergic beta-Agonists; Animals; Capillary Permeability; Chelating Agents; Cyclic AMP; Deferoxamine; Endothelium, Vascular; Hydrogen Peroxide; In Vitro Techniques; Isoproterenol; Lung; Male; Organ Size; Perfusion; Phosphodiesterase Inhibitors; Pyrimidinones; Rats; Rats, Sprague-Dawley; Serum Albumin, Bovine | 2000 |